Cargando...
Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I
Myotonic dystrophy Type I (DM1) is an autosomal dominant multi-system disorder characterized by myotonia and muscle weakness. Type 2 diabetes (T2D) and cancer have been shown to be part of the DM1 phenotype. Metformin, a well-established agent for the management of T2D, is thought to have cancer-pre...
Gardado en:
| Publicado en: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7336337/ https://ncbi.nlm.nih.gov/pubmed/31749144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32801 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|